Bausch Health Will Reduce Debt By $200 Million
Bausch Health Companies Inc. (NYSE/TSX: BHC) announced plans to reduce debt by $200 million by paying down senior secured term loans on March 31, 2022. This strategic move will be financed through cash generated from operations, demonstrating the company's commitment to improving its financial health. Bausch Health continues to focus on enhancing its portfolio in therapeutic areas such as eye health, gastroenterology, and dermatology.
- Reduction of debt by $200 million enhances financial stability.
- Debt paydown financed through operational cash flow indicates strong liquidity.
- None.
LAVAL, QC, March 29, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Caution Regarding Forward-Looking Information and "Safe Harbor" Statement
This news release may contain forward-looking statements, including, but not limited to, the reduction of the Company's debt through the paydown of its senior secured term loan, including the amount and timing thereof. Forward-looking statements may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the Company's most recent annual and quarterly reports and detailed from time to time in the Company's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Investor Contact: | Media Contact: |
Arthur Shannon | Lainie Keller |
(514) 856-3855 | (908) 927-1198 |
(877) 281-6642 (toll free) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-will-reduce-debt-by-200-million-301512236.html
SOURCE Bausch Health Companies Inc.
FAQ
What is Bausch Health's plan for debt reduction?
How will Bausch Health fund its debt reduction?
When is the debt paydown scheduled for Bausch Health?
What financial impact will Bausch Health's debt reduction have?
